Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading
cause of cancer-related death worldwide. Due to the lack of efficient tools for early detection …

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer with high
mortality. The realization of precision medicine in HCC relies upon efficient biomarkers …

Background Hepatocellular carcinoma lacks ideal diagnostic biomarkers. There is a lack of
scientific evaluation of relevant promising biomarkers as well. Therefore this study …

Ultrasound‐based surveillance has suboptimal sensitivity for early detection of
hepatocellular carcinoma (HCC) in patients with cirrhosis. There are several emerging …

Simple Summary Circulating biomarkers for the detection of hepatocellular carcinoma in
patients with dysmetabolic liver disease are an unmet need. In the present study, we …

This review explores various aspects of the HCC TME, including both cellular and non-
cellular components, to elucidate their roles in tumor development and progression …

Simple Summary Proteoglycans affect multiple molecular and cellular processes during the
progression of solid tumors with a highly desmoplastic stroma, such as HCC. Due to their …

Hepatocellular carcinoma (HCC) is a relevant complication occurring in individuals with
advanced Metabolic dysfunction-Associated Steatotic Liver Disease (MASLD). Recent …

The COVID-19 pandemic has forced us to direct most of the available resources towards its
management. This has led to the neglect of all other pathologies, including cancer. The aim …

Background and Objectives: the early diagnosis of hepatocellular carcinoma (HCC) benefits
from the use of alpha-fetoprotein (AFP) together with imaging diagnosis using abdominal …